Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Mutations in the androgen receptor gene cause various disorders.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Ghrelin and its receptors likely aren't risk factors for PCOS.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Finasteride increases CD8+ T cells in BPH tissues.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Blocking certain brain processes reduces mating behavior in female rats.

Progesterone protects brain cells, but Provera does not.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Certain genetic variants may increase the risk of developing PCOS.

Certain drugs that block specific enzymes can help treat prostate diseases.

Targeting neurosteroids may help prevent drug relapse.

Prostaglandins don't genetically contribute to hair loss.

PDGF and its receptors are crucial for stem cell growth and function.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Certain Dibenzo derivatives may help treat prostate cancer.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.